• SPX
  • 5969.34
  • 0.35 %
  • 20.6299
  • DJI
  • 44296.51
  • 0.97 %
  • 426.1602
  • N225
  • 38283.85
  • 0.68 %
  • 257.6797
  • FTSE
  • 8262.08
  • 1.38 %
  • 112.8101
  • IXIC
  • 19003.65
  • 0.16 %
  • 31.2305
Abbott Laboratories (ABT) Stock Price, News & Analysis

Abbott Laboratories (ABT) Stock Price, News & Analysis

Currency in USD Disclaimer

$117.72

$0.46

(0.39%)

Day's range
$116.38
Day's range
$118
50-day range
$111.68
Day's range
$121
  • Country: US
  • ISIN: US0028241000
52 wk range
$99.71
Day's range
$121.64


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 5.34
  • Piotroski Score 7.00
  • Grade Overweight
  • Symbol (ABT)
  • Company Abbott Laboratories
  • Price $117.72
  • Changes Percentage (0.39%)
  • Change $0.46
  • Day Low $116.38
  • Day High $118.00
  • Year High $121.64

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

  • Last Earnings 09/19/2024
  • Ex-Dividend for 5/16 Dividend 10/15/2024
  • Dividend Payable 11/15/2024
  • Today N/A
  • Next Earnings (Estimated) 01/22/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $128.00
  • High Stock Price Target $150.00
  • Low Stock Price Target $50.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $3.21
  • Trailing P/E Ratio 33.51
  • Forward P/E Ratio 33.51
  • P/E Growth 33.51
  • Net Income $5.72 B

Income Statement

Quarterly

Annual

Latest News of ABT

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Abbott Laboratories Frequently Asked Questions

  • What were the earnings of ABT in the last quarter?

    In the last quarter Abbott Laboratories earnings were on Wednesday, October, 16th. The Abbott Laboratories maker reported $1.21 EPS for the quarter, beating analysts' consensus estimates of $1.20 by $0.01.

  • What is the Abbott Laboratories stock price today?

    Today's price of Abbott Laboratories is $117.72 — it has increased by +0.39% in the past 24 hours. Watch Abbott Laboratories stock price performance more closely on the chart.

  • Does Abbott Laboratories release reports?

    Yes, you can track Abbott Laboratories's financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Abbott Laboratories stock forecast?

    Watch the Abbott Laboratories chart and read a more detailed Abbott Laboratories stock forecast to see what analysts suggest you do with its shares.

  • What is Abbott Laboratories stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NYSE, exchange stock trades by Abbott Laboratories stock ticker.

  • How to buy Abbott Laboratories stocks?

    Like other stocks, ABT shares are sold on stock exchanges such as NYSE. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Abbott Laboratories's EBITDA?

    Abbott Laboratories measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Abbott Laboratories’s financial statements.

  • What is the Abbott Laboratories's net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0.1426861802, which equates to approximately 14.27%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Abbott Laboratories stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Abbott Laboratories's financials relevant news, and technical analysis. Abbott Laboratories's technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Abbott Laboratories stock currently indicates a “sell” signal. For more insights, review Abbott Laboratories’s technical analysis.

  • A revenue figure for Abbott Laboratories for its last quarter?

    Abbott Laboratories published it's last quarterly revenues at $10.64 B.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.